These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26184453)

  • 1. Uncoupling of dopaminergic and subthalamic stimulation: Life-threatening DBS withdrawal syndrome.
    Reuter S; Deuschl G; Falk D; Mehdorn M; Witt K
    Mov Disord; 2015 Sep; 30(10):1407-13. PubMed ID: 26184453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation?
    Marques A; Fantini ML; Morand D; Pereira B; Derost P; Ulla M; Debilly B; Lemaire JJ; Durif F
    Sleep Med; 2015 May; 16(5):583-8. PubMed ID: 25881920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Zibetti M; Merola A; Rizzi L; Ricchi V; Angrisano S; Azzaro C; Artusi CA; Arduino N; Marchisio A; Lanotte M; Rizzone M; Lopiano L
    Mov Disord; 2011 Nov; 26(13):2327-34. PubMed ID: 22012750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic nucleus stimulation for Parkinson disease with severe medication-induced hallucinations or delusions.
    Umemura A; Oka Y; Okita K; Matsukawa N; Yamada K
    J Neurosurg; 2011 Jun; 114(6):1701-5. PubMed ID: 21375379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson's disease.
    Yamanaka T; Ishii F; Umemura A; Miyata M; Horiba M; Oka Y; Yamada K; Okita K; Matsukawa N; Ojika K
    Clin Neurol Neurosurg; 2012 May; 114(4):347-51. PubMed ID: 22176916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.
    Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C
    Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of unexpected long-term improvement of Parkinson's disease after subthalamic nucleus deep brain stimulation removal.
    Wong SH; Eldridge PR; Duffy A; Fox SH; Varma TR; Fletcher NA
    Br J Neurosurg; 2011 Apr; 25(2):281-3. PubMed ID: 21344961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twiddler syndrome in a patient with tremor dominant Parkinson's disease. A case report and literature review.
    Sobstyl M; Ząbek M; Górecki W; Brzuszkiewicz-Kuźmicka G
    Neurol Neurochir Pol; 2015; 49(6):467-71. PubMed ID: 26652885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine dysregulation syndrome after deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    De la Casa-Fages B; Grandas F
    J Neurol Sci; 2012 Jan; 312(1-2):191-3. PubMed ID: 21872889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical, medical, and hardware adverse events in a series of 141 patients undergoing subthalamic deep brain stimulation for Parkinson disease.
    Vergani F; Landi A; Pirillo D; Cilia R; Antonini A; Sganzerla EP
    World Neurosurg; 2010 Apr; 73(4):338-44. PubMed ID: 20849789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic deep brain stimulation and impulse control in Parkinson's disease.
    Hälbig TD; Tse W; Frisina PG; Baker BR; Hollander E; Shapiro H; Tagliati M; Koller WC; Olanow CW
    Eur J Neurol; 2009 Apr; 16(4):493-7. PubMed ID: 19236471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between bilateral subthalamic nucleus deep brain stimulation (STN-DBS) and anxiety in Parkinson's disease patients: a controlled study.
    Chang C; Li N; Wu Y; Geng N; Ge S; Wang J; Wang X; Wang X
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):316-25. PubMed ID: 23037645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome (parkinsonism-hyperpyrexia syndrome) after deep brain stimulation of the subthalamic nucleus.
    Urasaki E; Fukudome T; Hirose M; Nakane S; Matsuo H; Yamakawa Y
    J Clin Neurosci; 2013 May; 20(5):740-1. PubMed ID: 23465352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson's disease. Review of 272 procedures.
    Seijo FJ; Alvarez-Vega MA; Gutierrez JC; Fdez-Glez F; Lozano B
    Acta Neurochir (Wien); 2007; 149(9):867-75; discussion 876. PubMed ID: 17690838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.
    Liang GS; Chou KL; Baltuch GH; Jaggi JL; Loveland-Jones C; Leng L; Maccarone H; Hurtig HI; Colcher A; Stern MB; Kleiner-Fisman G; Simuni T; Siderowf AD
    Stereotact Funct Neurosurg; 2006; 84(5-6):221-7. PubMed ID: 17063043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.